TRT vs. cycle doses: is the 100–150 mg/week threshold real?

What's this video probably claiming?

Based on the caption, @coachgerardlewis is drawing a line in the sand that a lot of fitness influencers deliberately blur. The core argument appears to be that "TRT" and "health phase" have become euphemisms people use to make supraphysiologic testosterone use sound clinical or benign. The creator seems to be arguing that true therapeutic testosterone replacement sits at 100–150 mg per week, and that anything in the 300–500 mg range is a cycle, full stop. There's also an implied critique of coaches who fail to be honest with their clients about this distinction. This is a genuinely useful conversation to have, especially as TRT-adjacent language has flooded fitness social media and made it harder for patients seeking actual hypogonadism treatment to find accurate information. The question is whether the specific dose numbers hold up to clinical scrutiny.

What does the science actually show?

Legitimate TRT dosing ranges are well-documented. The American Urological Association and Endocrine Society both target serum testosterone levels in the 400–700 ng/dL range for hypogonadal men, which typically corresponds to weekly testosterone cypionate or enanthate injections of roughly 100–200 mg depending on the individual's metabolism and injection frequency. Bhasin et al. (2010, Journal of Clinical Endocrinology and Metabolism) established that doses of 25–125 mg per week in healthy men produced dose-dependent increases in lean mass and libido while remaining within or near physiologic ranges. Importantly, the same research group found that 300–600 mg per week produced substantially greater but clearly supraphysiologic anabolic effects, with corresponding increases in hematocrit, suppression of HDL, and left ventricular changes. The 100–150 mg ceiling the creator cites is broadly consistent with clinical guidelines, though some patients genuinely require up to 200 mg weekly to reach therapeutic trough levels. The 300–500 mg range is unambiguously performance-enhancing territory, not replacement.

Where does the social media noise diverge from clinical reality?

The fitness influencer ecosystem has effectively rebranded cycling as optimization. Terms like "health phase," "cruise dose," and "therapeutic dose" get applied to 200–400 mg weekly regimens that no endocrinologist would prescribe for a hypogonadal patient. This matters clinically because it creates a skewed baseline for patients who then arrive at telehealth platforms citing these doses as normal. Research by Pope et al. (2014, Drug and Alcohol Dependence) estimated that 2.9 to 4 million Americans have used anabolic-androgenic steroids, and self-reported "TRT" use among this population frequently describes supraphysiologic dosing. The bigger problem is that "cruise" doses of 200–300 mg per week are not harmless. Baggish et al. (2017, Circulation) found that long-term AAS users, including those on lower ongoing doses between cycles, showed significantly impaired left ventricular function compared to non-users. Calling a cycle a health phase does not change what it does to the cardiovascular system.

What should you actually know?

If you are considering testosterone therapy through a legitimate medical provider, the goal is to restore testosterone to a normal physiologic range, not to maximize it. Actual TRT is a monitored medical treatment involving baseline labs, follow-up testing, and dose adjustments based on serum levels, hematocrit, PSA, and symptom response. It is not a starting point for performance enhancement. The dose ranges the creator cites are directionally accurate: 100–150 mg per week aligns with standard clinical starting points for most patients using weekly injections, though individual pharmacokinetics vary enough that some men need modestly higher doses to stay within range. Anyone telling you that 300 mg weekly is still "just TRT" is either misinformed or has an incentive to obscure the distinction. The creator's broader point, that the fitness community has co-opted clinical language, is well-supported and worth taking seriously.